BioSpace News Archive

BioMidwest

ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the submission of a De Novo request to the U.S. Food and Drug Administration (FDA) for the TAEUS system.

August 14, 2023
·
5 min read
BioMidwest

Longeveron Announces Pricing for Rights Offering and Expected Calendar

Longeveron Inc. announced that it has filed an amended registration statement with the Securities and Exchange Commission to conduct a tradable subscription rights offering to holders of its Class A common stock, Class B common stock and warrants to purchase its Class A common stock.

August 14, 2023
·
7 min read
Business

Enveric Biosciences Reports Second Quarter 2023 Corporate and Financial Results

Enveric Biosciences, Inc. today provided a corporate update and reported financial results for the second quarter of 2023 ended June 30, 2023.

August 14, 2023
·
8 min read
Biotech Beach

Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference

Biocept, Inc . (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, announces that its CNSide cerebrospinal fluid assay was featured in two oral presentations at the 2023 SNO/ASCO CNS Cancer Conference on Saturday, August 12.

August 14, 2023
·
5 min read
Business

VBI Vaccines Reports Second Quarter 2023 Financial Results

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended June 30, 2023.

August 14, 2023
·
16 min read
Pharm Country

Halberd-Mississippi State University (MSU) Testing of TBI Nasal Spray Progresses

Halberd Corporation’s Traumatic Brain Injury mitigation research on Halberd’s patent-pending nasal spray continues at Mississippi State University.

August 14, 2023
·
4 min read
Business

Jaguar Health Reports Second Quarter 2023 Financial Results

Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) today reported consolidated second-quarter 2023 financial results and provided Company updates.

August 14, 2023
·
13 min read
Biotech Bay

Turn Biotechnologies Cell Reprogramming Treatment Showcased in AAD’s First Session on Regenerative Therapies

The first American Academy of Dermatology educational session to discuss the potential of regenerative medicine in dermatologic treatments featured data from Turn Biotechnologies’ ERA™ technology’s reprogramming of skin cells.

August 14, 2023
·
3 min read
Business

Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th

Biotricity Inc. announced that it will host its First Quarter Fiscal Year 2024 Financial Results and Business Update Call on Tuesday, August 15, 2023.

August 14, 2023
·
4 min read
Drug Development

SFA Therapeutics announces results for SFA-002 from Phase 1b Cohort 1 clinical trial for treatment of mild-to-moderate psoriasis

SFA Therapeutics, a clinical-stage biotech using a first-in-class immuno-modulation technology platform, announced positive results from their SFA-002 Phase 1b cohort 1 clinical trial.

August 14, 2023
·
3 min read